234 related articles for article (PubMed ID: 17071752)
1. Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.
Davis AJ; Mecsas J
J Bacteriol; 2007 Jan; 189(1):83-97. PubMed ID: 17071752
[TBL] [Abstract][Full Text] [Related]
2. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
Harmon DE; Murphy JL; Davis AJ; Mecsas J
J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
[TBL] [Abstract][Full Text] [Related]
3. A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia.
Davis AJ; Díaz DA; Mecsas J
Mol Microbiol; 2010 Apr; 76(1):236-59. PubMed ID: 20199604
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
Marenne MN; Journet L; Mota LJ; Cornelis GR
Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
[TBL] [Abstract][Full Text] [Related]
5. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
6. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
Sundberg L; Forsberg A
Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.
Harmon DE; Davis AJ; Castillo C; Mecsas J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3241-54. PubMed ID: 20498321
[TBL] [Abstract][Full Text] [Related]
8. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
Adams W; Morgan J; Kwuan L; Auerbuch V
Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
[TBL] [Abstract][Full Text] [Related]
9. An Interaction between the Inner Rod Protein YscI and the Needle Protein YscF Is Required to Assemble the Needle Structure of the
Cao SY; Liu WB; Tan YF; Yang HY; Zhang TT; Wang T; Wang XY; Song YJ; Yang RF; Du ZM
J Biol Chem; 2017 Mar; 292(13):5488-5498. PubMed ID: 28196868
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
12. Autoproteolysis of YscU of Yersinia pseudotuberculosis is important for regulation of expression and secretion of Yop proteins.
Björnfot AC; Lavander M; Forsberg A; Wolf-Watz H
J Bacteriol; 2009 Jul; 191(13):4259-67. PubMed ID: 19395493
[TBL] [Abstract][Full Text] [Related]
13. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
Francis MS; Wolf-Watz H
Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
[TBL] [Abstract][Full Text] [Related]
14. YscU/FlhB of Yersinia pseudotuberculosis Harbors a C-terminal Type III Secretion Signal.
Login FH; Wolf-Watz H
J Biol Chem; 2015 Oct; 290(43):26282-91. PubMed ID: 26338709
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses.
Osei-Owusu P; Jessen Condry DL; Toosky M; Roughead W; Bradley DS; Nilles ML
Infect Immun; 2015 Apr; 83(4):1507-22. PubMed ID: 25644012
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of the Yersinia pestis type III secretion system needle protein YscF in complex with its heterodimeric chaperone YscE/YscG.
Sun P; Tropea JE; Austin BP; Cherry S; Waugh DS
J Mol Biol; 2008 Mar; 377(3):819-30. PubMed ID: 18281060
[TBL] [Abstract][Full Text] [Related]
17. Type III secretion translocon assemblies that attenuate Yersinia virulence.
Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
[TBL] [Abstract][Full Text] [Related]
18. The YscE/YscG chaperone and YscF N-terminal sequences target YscF to the Yersinia pestis type III secretion apparatus.
Souza CA; Richards KL; Park Y; Schwartz M; Torruellas Garcia J; Schesser Bartra S; Plano GV
Microbiology (Reading); 2018 Mar; 164(3):338-348. PubMed ID: 29458689
[TBL] [Abstract][Full Text] [Related]
19. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
Zhang Y; Romanov G; Bliska JB
Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228
[TBL] [Abstract][Full Text] [Related]
20. YscP and YscU switch the substrate specificity of the Yersinia type III secretion system by regulating export of the inner rod protein YscI.
Wood SE; Jin J; Lloyd SA
J Bacteriol; 2008 Jun; 190(12):4252-62. PubMed ID: 18424518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
